As disciplines go, pharmacoeconomics is in its relative infancy. And what direction it will take as it matures is up for discussion. As we face the new millennium, selected members of the editorial board forPharmacoEconomics & Outcomes Newsoffer their musings on what the future holds for pharmacoeconomics.